Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.

Documenti analoghi

• Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway
  di: Ahmed M. Samy, et al.
  Pubblicazione: (2024)
• Investigation of the Expression Levels of miR ‐383, miR ‐381, and miR ‐141 miRNAs as Diagnostic Biomarkers in Acute Myeloid Leukemia
  di: Mayyadah Ali Ahmed AL‐Gburi, et al.
  Pubblicazione: (2026)
• Retracted: Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction
  di: BioMed Research International
  Pubblicazione: (2024)
• Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer
  di: Hersh Abdul Ham‐Karim
  Pubblicazione: (2025)
• Are miR‐26a and miR‐26b microRNAs potent prognostic markers of gestational diabetes?
  di: Hori Ghaneialvar, et al.
  Pubblicazione: (2024)